Addressing DOJ’s New Compliance Focus on Executive Compensation - McDermott

Addressing DOJ’s New Compliance Focus on Executive Compensation


Download the takeaways here.

The new compliance focus on executive compensation, as announced by the US Department of Justice (DOJ) on March 3, 2023, has significant implications for how healthcare organizations address both corporate compliance and compensation programs for their executives. It also raises new issues for the board of directors’ oversight of compliance and compensation functions.

Thought leaders in compensation, compliance, corporate law and governance from McDermott and SullivanCotter will discuss these and related issues in an engaging roundtable webinar, dropping on April 20. The conversation will focus on important practical issues such as the following:

  • What is DOJ’s “end game” with the new compliance guidelines?
  • Is the executive compensation focus binding for healthcare organizations?
  • What kinds of financial incentives is DOJ examining?
  • What is the special concentration on executive “clawbacks?”
  • What should healthcare organizations know about the US Securities and Exchange Commission’s parallel focus on clawback?
  • How can organizations effectively balance board oversight by the compliance and executive compensation committees?
  • What actions should the Executive Compensation Committee consider in light of DOJs guidance?

Dig Deeper

Miami, FL / McDermott Event / March 6-7, 2024

HPE Miami 2024

New York, NY / McDermott Event / October 13, 2023

HPE NYC 2023

London, UK / McDermott Event / September 21, 2023

HPE Europe 2023

San Francisco, CA / McDermott Event / June 27, 2023

AHLA Annual Meeting Reception 2023

San Francisco, CA / AHLA / June 26 - 28, 2023

AHLA Annual Meeting 2023

San Diego, CA / AIMed / June 4 - 7, 2023

AIMed Global Summit 2023

Get In Touch